Association of the enkephalinase gene with low amplitude P300 waves

NeuroReport

Volumn 10, Issue 11, 1999, Pages 2283-2285

  Comings, David E ^c   Dietz, George ^c   Johnson, J Patrick ^a   MacMurray, James P ^b  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

Enkephalin; Evoked potential; Opioids; Substance abuse

Indexed keywords

ENKEPHALIN; MEMBRANE METALLOENDOPEPTIDASE; OPIATE;

ARTICLE; CLINICAL ARTICLE; DNA POLYMORPHISM; ELECTROPHYSIOLOGY; EVENT RELATED POTENTIAL; EVOKED RESPONSE; HUMAN; MALE; PRIORITY JOURNAL; REGULATORY MECHANISM; SUBSTANCE ABUSE;

EID: 0033516940     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199908020-00011     Document Type: Article

References (30)

1. 1. Morley JE, Levine GK, Yim GK et al. Neurosci Biobehav Rev 7, 281 (1983).
2. 2. Olson GA, Olson RD and Kastin AJK. Peptides 17, 1421-1466 (1996).
3. 3. Virkkunen ME, Horrobin DF, Jenkins DK and Manku MS. Biol Psychiatry 22, 1087-1096 (1987).
4. 4. Blum K, Trachtenberg MC, Elliott CE et al. Alcohols 5, 481-493 (1989).
5. 5. Gianoulakis C, Krishnan B and Thavundayil J. Arch Gen Psychiatry 53, 250-257 (1996).
6. 6. Wand GS, Mangold D, El Deiry S et al. Arch Gen Psychiatry 55, 1114-1119 (1998).
7. 7. Comings DE, Blake H, Dietz G et al. NeuroReport 10 1133-1135, (1999).
8. 8. Lerche C, Vogel LK, Shapiro LH et al. Mammalian Genome 7, 712-713 (1996).
9. 9. Johnson JP, Dietz G, Gade-Andavolu R et al. Am J Med Genet (Neuropsych Genet) 81, 524 (1998).
10. 10. Huss M, Kunkel G and Lehmkuhl U. Am J Med Genet (Neuropsych Genet) 81, 549 (1998).
11. 11. Begleiter H, Porgesz B, Bihad B and Kissin B. Science 225, 1493-1495 (1984).
12. 12. Polich J, Pollock VE and Bloom FE. Psychological Bull 115, 55-73 (1994).
13. 13. Benegal V, Jain S, Subbukrishna DK and Channabasavanna SM. Psychiat Genet 5, 149-156 (1995).
14. 14. Hill SY, Muka D, Steinhauer S and Locke J. Biol Psychiatry 38, 622-632 (1955).
15. 15. Polich J. Am J EEG Technol 31, 201-231 (1991).
16. 16. Haouas H, Morello D, et al. Biochem Biophys Res Commun 207, 933-942 (1995).
17. 17. Comings DE, Mol Psychiatry 3, 21-31 (1998).
18. 18. Blum K, Briggs AH, Trachtenberg MC et al. Alcohol 4, 449-456 (1987).
19. 19. Blum K, Briggs AH, Elaton SF and DeLallo L. Toxicol Eur Res 3, 261-262 (1981).
20. 20. Johnson JP, Muhleman G, MacMurray J, et al. Mol Psychiatry 2, 169-171 (1997).
21. 21. Noble EP, Berman SM, Orkaragoz TZ and Ritchie T. Am J Hum Genet 54, 658-668 (1994).
22. 22. Blum K, Braverman ER, Wood RC and Sheridan PJ. Am J Hum Genet 55, A146 (1994).
23. 23. Hill SY, Locke J. Zezza N et al. Biol Psychiatry 43, 40-51 (1998).
24. 24. Bolos AM, Dsan M, Lucas-Derse S et al. J Am Med Assoc 26, 3156-3160 (1990).
25. 25. Blum K, Noble EP, Sheridan PJ et al. J Am Med Assoc 263, 2055-2059 (1990).
26. 26. Noble EP. Behav Genet 23, 119-129 (1993).
27. 27. Blum K, Wood RC, Sheridan PJ et al. Pharmacogenetics 5, 121-141 (1995).
28. 28. Kalivas PW, Duffy P, Dills R and Abhold R. Ann NY Acad Sci 537, 403-414 (1988).
29. 29. Lu X-Y, Ghasemzadeh MB and Kalivas PW. Neuroscience 82, 767-780 (1998).
30. 30. LeMoine C and Bloch B. J Comp Neurol 355, 426-481 (1995).